Technology
Health
Pharmaceutical

argenx SE

$131.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.85 (-1.38%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell argenx SE and other stocks, options, ETFs, and crypto commission-free!

About

argenx SE American Depositary Shares, also called argenx SE, is a clinical-stage biotechnology company, which engages in the research and development of human monoclonal antibodies for the treatment of cancer and oncological, autoimmune, and inflammatory diseases. Its products include ARGX-113 for severe autoimmune diseases and ARGX-110 for T-cell lymphoma and acute myeloid leukemia. Read More It operates through the following geographical segments: Netherlands, Belgium, Germany, Denmark, Switzerland, United States, and Luxemburg. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.

Employees
73
Headquarters
Breda, Noord-Brabant
Founded
2008
Market Cap
4.34B
Price-Earnings Ratio
Dividend Yield
Average Volume
184.60K
High Today
$133.05
Low Today
$131.33
Open Price
$132.93
Volume
36.60K
52 Week High
$135.58
52 Week Low
$63.81

Collections

Technology
Health
Pharmaceutical
Medical
Biotechnology
Research And Development
Cancer Prevention
2017 IPO

Earnings

-$0.90
-$0.60
-$0.29
$0.01
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available May 9, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.